Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2011 - 09 - 09

Denial of article published in "Il mondo"

Florence, September 9, 2011


In relation to the article published today by the business weekly "Il Mondo" no. 33 of 2011, entitled "Menarini, the future of the Leading Italian Pharmaceutical Industry. Recipes for the Aleotti Family from Mediobanca", the Aleotti family categorically denies the news, entirely without grounds, about an alleged mandate given to Mediobanca for a possible agreement with a private equity fund, or an alliance with a major pharmaceutical company or the sale of the Menarini parent company or its listing on the stock exchange or any similar corporate transaction. It strongly reaffirms the absolute falsity of such news given that no sort of mandate, not even exploratory, was given to Mediobanca or any other institutions in relation to such hypotheses which have never been taken into consideration by the ownership.

To the contrary, the Aleotti family wishes to emphasize its total commitment to continuing the pursuit of development and internationalization of the Menarini Group, in complete independence.
Mandate has also been given to its attorneys to assess possible actions to be taken for the protection of the truth and image of Menarini.